Sulfasalazine 1000 MG Delayed Release Tablets – SUFEXIA 1000 DR Tablets

SUFEXIA 1000 DR Tablets
Composition:- Sulfasalazine 1000 mg Delayed Release

SUFEXIA 1000 DR Tablets – The composition of Sulfasalazine 1000 MG Delayed ReleaseTablets is a disease-modifying anti-rheumatic drug (DMARD) and anti-inflammatory agent. It is metabolized into 5-aminosalicylic acid (5-ASA), which reduces inflammation in the gut, and sulfapyridine, which modulates immune activity, making it effective for both joint and gastrointestinal conditions.
Marketed by: Wonne International Pvt. Ltd.

Key Points of Sulfasalazine 1000 MG Delayed Release Tablets – SUFEXIA 1000 DR Tablets

• Dual Anti-Inflammatory Action – Works as both an immunomodulator and anti-inflammatory agent, effectively managing chronic inflammatory conditions.
• Targeted Relief for Autoimmune Diseases – Specifically formulated to reduce inflammation, swelling, and pain in rheumatoid arthritis and inflammatory bowel disease.
• Colonic-Specific Activation – Metabolized in the colon into 5-ASA (anti-inflammatory) and sulfapyridine (immunomodulator), ensuring localized action in the gut.

• Orthopedic Surgeons
• Rheumatologists
• General Physicians
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.